Steve said in the latest presentation that top line results for the ph2 Camp/ETEC trial will be announced in August .
The initial trial completion date was changed months ago.
The trial completion date doesn’t mean much imo. Provably just the trial review and follow up stage, more of a formality. But who knows.
If the results are good there’s going to be a lot more interest in Immuron’s technology. Ears will prick up.
This is a proper trial run by a highly respected organization. Campylobacter and the overuse of antibiotics are both serious problems that Immurons tech could help solve
What I like is the trials are quick to run and cheap.
Ann: Immuron CEO to present at Emerging Growth Conference, page-8
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.93M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.5¢ | $1.158K | 11.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9352 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 251204 | 4 |
View Market Depth
| Last trade - 10.48am 27/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |